Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pea protein vs. whey: which preserves muscle better during weight loss?

NCT ID NCT04123938

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tested whether pea protein can help people with obesity preserve muscle mass while losing weight, compared to whey protein. Sixty adults aged 30 to 50 followed a weight loss regimen and took either pea protein, whey protein, or a non-protein control. Researchers measured changes in muscle mass, strength, and function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pea protein
What this could lead to
If it works, this could point toward a plant-based alternative to whey protein for maintaining muscle during weight loss.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to everyone. It also compares pea protein to whey protein, not to a placebo, so any benefit may be similar to other protein sources.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Oct 2019

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male, or non-pregnant, non-lactating female, 30 to 50 years of age; 2. BMI \>30 and body weight does not exceed the capacity of the DEXA (350 lbs); 3. Fat mass \>23% for males and \>32% for females (determined at the screening visit via bioelectrical impedance); 4. Willing to maintain a stable level of activity while participating in the study; 5. Plasma creatinine ≤265 µmol/L; 6. Plasma LDL-cholesterol \<5 mmol/L; 7. Aspartate aminotransferase \<160 U/L, and alanine aminotransferase \<150 U/L; 8. Glycated hemoglobin \<6.5%; 9. Blood pressure \<160 mmHg systolic and \<100 mmHg diastolic; 10. Stable regime if taking vitamin and mineral/dietary/herbal supplements for the past 1 month and while participating in the study; 11. Not taking protein supplements for the past month and willing to continue doing so for the duration of the study; 12. Has not donated blood or blood products (e.g. platelets) during the past 2 months and willing to continue doing so while participating in the study; 13. Female participants of child-bearing potential must agree to use a highly effective method of contraception throughout the study; 14. Not participating in another dietary intervention trial for the past month and willing to not start another dietary intervention trial or weight loss program for the duration of this study; 15. Willing to comply with the protocol requirements and procedures; 16. Willing to provide informed consent. Exclusion Criteria: 1. Has experienced a cardiovascular event (e.g. heart attack, stroke) or had a surgical procedure for cardiovascular disease (e.g. bypass, stent), presence of diabetes, chronic renal disease, liver disease (with exception of fatty liver), rheumatoid arthritis, immune disorder or disease (e.g. multiple sclerosis, leukemia), cancer in the previous 5 years, neurological disorders, gastrointestinal disorders or gastrointestinal surgery or bariatric surgery, or liposuction; 2. Taking medications for blood glucose management; 3. Taking medications or natural health products/supplements associated with weight gain or weight loss (e.g. prednisone, certain cold medications); 4. Body weight that has not been stable (± 5%) over the past 3 months; 5. History of gastrointestinal reactions or allergies to peas, pea protein, whey protein or maltodextrin, or to one or more ingredients in the beverages and foods that will be provided which significantly limits the number of items that can be used for delivery of the protein powders or maltodextrin; 6. Current (within the past 30 days) bacterial, viral or fungal infection; 7. Uncontrolled hypothyroidism; 8. Uncontrolled blood pressure; 9. Bleeding disorder; 10. Any acute medical condition or surgical intervention within the past 3 months; 11. Cigarette/cigar smoking or use of tobacco products within the last 12 months or during participation in the study; 12. Consumption of \>10 alcoholic beverages per week or \>2 alcoholic beverages per day within the last 3 months or while participating in the study; 13. Drug and/or alcohol abuse; 14. Psychological disorder(s); 15. Unable to obtain blood sample at the screening or week 0 visits.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • I.H Asper Clinical Research Institute, St. Boniface Hospital

    Winnipeg, Manitoba, R2H 2A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.